Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Rigel Pharmaceutical (RIGL)

3.84 -0.22 (-5.42%)

04-20 16:00

Open:

4.1

Pre. Close:

4.06

High:

4.1899

Low:

3.73

Volume:

15,016,919

Market Cap:

566M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.2 - 4.22

4.22 - 4.237

Low:

3.678 - 3.703

3.703 - 3.724

Close:

3.803 - 3.843

3.843 - 3.875

Technical analysis  (as of: 2018-04-20 4:33:11 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 5.47     One year: 6.38

Support:

Support1: 3.41    Support2: 2.63

Resistance:

Resistance1: 4.68    Resistance2: 5.47

Pivot:

3.58

Moving Averages:

MA(5): 3.92     MA(20): 3.61

MA(100): 3.88     MA(250): 3.27

MACD:

MACD(12,26): 0.02     Signal(12,26,9): -0.05

%K %D:

%K(14,3): 63.25     %D(3): 64.39

RSI:

RSI(14): 51.75

52-Week:

High: 4.71  Low: 2.14  Change(%): 30.2

Average Vol(K):

3-Month: 271147  10-Days 817325

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
RIGL has closed below upper band by 31.4%. Bollinger Bands are 62.2% wider than normal. The large width of the bands suggest high volatility as compared to RIGL's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

2018-04-19T19:31:00-04:00
Rigel Announces Pricing Of Public Offering Of Common Stock

2018-04-18T17:39:49-04:00
After Hours Gainers / Losers (04/18/2018)

2018-04-18T17:28:22-04:00
Rigel Pharmaceuticals (RIGL) FDA Approval Of TAVALISSE(TM) - Slideshow

2018-04-18T16:34:00-04:00
Rigel Announces Proposed Public Offering Of Common Stock

2018-04-18T02:43:05-04:00
Rigel Overcomes Its First FDA Approval Barrier, Is There More To Come?

2018-04-17T16:51:00-04:00
Rigel Announces FDA Approval of TAVALISSE(TM) (fostamatinib disodium hexahydrate) for Chronic Immune Thrombocytopenia (ITP) in Adult Patients

2018-04-17T13:43:41-04:00
Trading in Rigel halted ahead of expected FDA OK for Tavalisse for immune thrombocytopenia; shares up 10%

2018-04-17T08:00:00-04:00
3 Things In Biotech, April 16: Liver, Liver, And More Liver

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

147.37

Shares Float (M)

147.06

% Held by Insiders

0.20

% Held by Institutions

92.30

Shares Short (K)

9612

Shares Short Prior Month (K)

6030

Stock Financials

EPS

-0.610

EPS Est. Current Year

-0.600

EPS Est. Next Year

-0.430

EPS Est. Next Quarter

-0.150

Forward EPS

-0.470

Book Value (p.s.)

5.730

PEG Ratio

-0.08

Profit Margin

Operating Margin

-1775.56

Return on Assets (ttm)

-79.1

Return on Equity (ttm)

-100.2

Qtrly Rev. Growth

-100.0

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.360

Qtrly Earnings Growth

Operating Cash Flow (M)

-77.56

Levered Free Cash Flow (M)

-47.96

atoplab.com

Valuation

P/E

-6.30

P/E Growth Ratio

-0.05

P/BV

0.67

P/S

14147519488.00

P/CF

-7.30

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.